Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pedersen

Showing results (321-330 of 390) with videos related to

Pageof 39
Sort By:
Phytochemistry|May 28, 2017
Iridoid glucosides in the genus Veronica (Plantaginaceae) from New ZealandPhillip Kroll-Møller, Katja D Pedersen, Chrysoula Gousiadou, et al.
Veterinary Pathology|February 26, 2020
Myocardial Changes in Diabetic and Nondiabetic Nonhuman PrimatesSimone Krog, Trine P Ludvigsen, Ole L Nielsen, et al.
EULAR Rheumatology Open|June 29, 2026
Open-access clinic for arthralgia: patient flow and diagnostic pathways-a retrospective cohort studyElisabeth L Nielsen, Kresten K Keller, Jesper B Nissen, et al.
Diabetes, Obesity & Metabolism|September 13, 2021
Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight lossSean Wharton, Salvatore Calanna, Melanie Davies, et al.
Human Reproduction (Oxford, England)|June 30, 2018
The impact of luteal serum progesterone levels on live birth rates-a prospective study of 602 IVF/ICSI cyclesL H Thomsen, U S Kesmodel, K Erb, et al.
Lancet (London, England)|March 5, 2021
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trialMelanie Davies, Louise Færch, Ole K Jeppesen, et al.
Journal of Veterinary Internal Medicine|June 5, 2013
Left ventricular twist and circumferential strain in dogs with myxomatous mitral valve diseaseN E Zois, N T Olsen, S G Moesgaard, et al.
BMC Cardiovascular Disorders|June 21, 2011
COPE-ICD: a randomised clinical trial studying the effects and meaning of a comprehensive rehabilitation programme for ICD recipients -design, intervention and populationSelina K Berg, Jesper H Svendsen, Ann-Dorthe Zwisler, et al.
Inflammatory Bowel Diseases|June 1, 2018
Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving TofacitinibKevin L Winthrop, Gil Y Melmed, Séverine Vermeire, et al.
The Lancet. Diabetes & Endocrinology|August 1, 2024
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trialBarbara M McGowan, Jens M Bruun, Matt Capehorn, et al.
Pageof 39

Showing results (321-330 of 390) with videos related to

Sort By:
Pageof 39
Phytochemistry|May 28, 2017
Iridoid glucosides in the genus Veronica (Plantaginaceae) from New ZealandPhillip Kroll-Møller, Katja D Pedersen, Chrysoula Gousiadou, et al.
Veterinary Pathology|February 26, 2020
Myocardial Changes in Diabetic and Nondiabetic Nonhuman PrimatesSimone Krog, Trine P Ludvigsen, Ole L Nielsen, et al.
EULAR Rheumatology Open|June 29, 2026
Open-access clinic for arthralgia: patient flow and diagnostic pathways-a retrospective cohort studyElisabeth L Nielsen, Kresten K Keller, Jesper B Nissen, et al.
Diabetes, Obesity & Metabolism|September 13, 2021
Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight lossSean Wharton, Salvatore Calanna, Melanie Davies, et al.
Human Reproduction (Oxford, England)|June 30, 2018
The impact of luteal serum progesterone levels on live birth rates-a prospective study of 602 IVF/ICSI cyclesL H Thomsen, U S Kesmodel, K Erb, et al.
Lancet (London, England)|March 5, 2021
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trialMelanie Davies, Louise Færch, Ole K Jeppesen, et al.
Journal of Veterinary Internal Medicine|June 5, 2013
Left ventricular twist and circumferential strain in dogs with myxomatous mitral valve diseaseN E Zois, N T Olsen, S G Moesgaard, et al.
BMC Cardiovascular Disorders|June 21, 2011
COPE-ICD: a randomised clinical trial studying the effects and meaning of a comprehensive rehabilitation programme for ICD recipients -design, intervention and populationSelina K Berg, Jesper H Svendsen, Ann-Dorthe Zwisler, et al.
Inflammatory Bowel Diseases|June 1, 2018
Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving TofacitinibKevin L Winthrop, Gil Y Melmed, Séverine Vermeire, et al.
The Lancet. Diabetes & Endocrinology|August 1, 2024
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trialBarbara M McGowan, Jens M Bruun, Matt Capehorn, et al.
Pageof 39